|
Welcome back Rounds Table Listeners!
In this throwback episode, Mike and John explore two papers exploring the use of SGLT-2 Inhibitors in heart failure. Check it out below!
-
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction (0:00 – 7:20).
-
SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials (7:20 – 15:45).
And for the Good Stuff:
Questions? Comments? Feedback? We’d love to hear from you! @roundstable The post TBT – SGLT-2 Inhibitors in Heart Failure first appeared on Healthy Debate. The post TBT – SGLT-2 Inhibitors in Heart Failure appeared first on Healthy Debate. |